Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) Releases Quarterly Earnings Results

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) released its quarterly earnings results on Thursday. The company reported ($0.07) earnings per share for the quarter, FiscalAI reports. The company had revenue of $0.78 million during the quarter.

Inspira Technologies OXY B.H.N. Stock Performance

NASDAQ QTEX opened at $0.76 on Friday. The company has a current ratio of 1.56, a quick ratio of 1.30 and a debt-to-equity ratio of 0.08. The firm has a 50 day moving average price of $0.91. Inspira Technologies OXY B.H.N. has a 1-year low of $0.28 and a 1-year high of $3.85.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Weiss Ratings restated a “sell (e+)” rating on shares of Inspira Technologies OXY B.H.N. in a research report on Monday, August 24th. Wall Street Zen lowered shares of Inspira Technologies OXY B.H.N. from a “hold” rating to a “sell” rating in a report on Saturday, August 8th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has an average rating of “Sell”.

Inspira Technologies OXY B.H.N. declared that its board has authorized a stock repurchase plan on Monday, June 22nd that permits the company to repurchase 2,000,000,000,000 outstanding shares. This repurchase authorization permits the company to buy up to 5.6% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s board of directors believes its stock is undervalued.

About Inspira Technologies OXY B.H.N.

Inspira Technologies OXY B.H.N. Ltd. is an Israeli medical technology company focused on developing advanced respiratory-support systems for patients experiencing acute respiratory failure. The company’s technology is intended to support blood oxygenation and carbon-dioxide removal while potentially reducing reliance on invasive mechanical ventilation.

Its principal product platform is the INSPIRA ART system, an extracorporeal respiratory-support technology designed to oxygenate blood outside the body and return it to the patient.